Thorkil Kastberg Christensen
Plus aucun poste en cours
Profil
Thorkil Kastberg Christensen formerly worked at Novo Nordisk China, as Chief Executive Officer, Danish-Chinese Business Forum, as Vice Chairman, BioMimetic Therapeutics, Inc., as Director, Executives' Global Network A, as Director, Novo Industri A, as Director-Finance & Investor Relations, Jørgen Kruuse A, as Director, Novo Nordisk A, as Vice President-International Operations from 1978 to 2003, Novo Holdings AS (Denmark), as Chief Financial Officer from 2003 to 2015, and Novo Principal Investments, as Chief Financial Officer from 2003 to 2015.
Anciens postes connus de Thorkil Kastberg Christensen
| Sociétés | Poste | Fin |
|---|---|---|
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Directeur Financier/CFO | 31/12/2015 |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Directeur Financier/CFO | 01/04/2015 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Jørgen Kruuse A/S
 Jørgen Kruuse A/S Medical DistributorsDistribution Services Jørgen Kruuse A/S manufactures and supplies veterinary products needed in the treatment and care of animals with worldwide distribution. Its brands include KRUUSE, BUSTER, KRUTEX, VALUELINE, EQUIVET and BOVIVET. The company was founded in 1939 and is headquartered in Langeskov, Denmark. | Directeur/Membre du Conseil | - |
Novo Nordisk China
 Novo Nordisk China Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Entreprise privées | 8 |
|---|---|
BioMimetic Therapeutics, Inc.
 BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Health Technology |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
| Executives' Global Network A/S | Commercial Services |
Danish-Chinese Business Forum
 Danish-Chinese Business Forum Miscellaneous Commercial ServicesCommercial Services Danish-Chinese Business Forum is an executive networking platform that aims to improve business relations between Denmark and China. The non-profit company is based in Copenhagen, Denmark. Additionally, the provided dictionary includes information about two other companies. The first is a family-owned Danish Pharmaceutical Industry that specializes in providing quality food supplements with natural vitamins and organic minerals. The second is Royal Arctic Line, which offers ocean and coastal liner services to, from, and within Greenland, as well as port operations and warehouse management in 13 ports. | Commercial Services |
| Novo Industri A/S | Health Technology |
Novo Nordisk China
Novo Nordisk China Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders. | Health Technology |
Jørgen Kruuse A/S
Jørgen Kruuse A/S Medical DistributorsDistribution Services Jørgen Kruuse A/S manufactures and supplies veterinary products needed in the treatment and care of animals with worldwide distribution. Its brands include KRUUSE, BUSTER, KRUTEX, VALUELINE, EQUIVET and BOVIVET. The company was founded in 1939 and is headquartered in Langeskov, Denmark. | Distribution Services |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
